Primary outcome measures | The proportion of patients in each practice: |
 | 1. With a history of peptic ulcer being prescribed non-selective non-steroidal anti-inflammatory drugs |
 | 2. With a history of asthma being prescribed beta-blockers |
 | 3. Aged 75 years and older receiving long-term prescriptions for angiotensin-converting enzyme inhibitors or loop diuretics without a recorded assessment of renal function and electrolytes in the preceding 15 months. |
 | 4. Proportions of women with a past medical history of venous or arterial thrombosis who have been prescribed the combined oral contraceptive pill |
Secondary outcome measures | 5. Patients receiving methotrexate for at least three months who have not had a recorded full blood count and/or liver function test within the previous three months |
 | 6. Patients receiving warfarin for at least three months who have not had a recorded check of their international normalized ratio within the previous 12 weeks |
 | 7. Patients receiving lithium for at least three months who have not had a recorded check of their lithium levels within the previous three months |
 | 8. Patients receiving amiodarone for at least six months who have not had a thyroid function test within the previous six months |
 | 9. Patients receiving prescriptions of methotrexate without instructions that the drug should be taken weekly |
 | 10. Patients receiving prescriptions of amiodarone for at least one month who were receiving a dose of more than 200 mg per day. |